Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Data Collection × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Pancreatic Cyst 1 Neoplasms 1 Neoplasm Metastasis 1 Hip Fractures 1 Glioma 1 Glioblastoma 1 Fractures, Spontaneous 1 Dysplastic Nevus Syndrome 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 COVID-19 1 Brain Neoplasms 1 Ataxia Telangiectasia 1

Interventions

pembrolizumab 22 Bevacizumab 15 Nivolumab 11 Cyclophosphamide 11 Blood Specimen Collection 10 Paclitaxel 9 Gemcitabine 9 Carboplatin 9 Pemetrexed 7 Doxorubicin 7 atezolizumab 6 Rituximab 6 Magnetic Resonance Spectroscopy 6 Fluorouracil 6 Docetaxel 6 Cisplatin 6 Cetuximab 6 fludarabine 5 Temozolomide 5 Surveys and Questionnaires 5 Oxaliplatin 5 Leucovorin 5 Biopsy 5 olaparib 4 durvalumab 4 abemaciclib 4 Specimen Handling 4 Prednisone 4 Methods 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04477681 2026-03-31

SACHA

Gustave Roussy, Cancer Campus, Grand Paris

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡